AAAAAA
Results:
1-23
|
Results: 23
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Louvet, C
Andre, T
Hammel, P
Selle, F
Landi, B
Cattan, S
Fonck, M
Flesch, M
Colin, P
Balosso, J
Ruszniewski, P
de Gramont, A
Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679
Authors:
Louvet, C
Citation: C. Louvet, New chemotherapies for colorectal cancer treatment, GASTRO CL B, 25(4), 2001, pp. B51-B56
Authors:
Vedrine, L
Artru, P
Tournigand, C
Louvet, C
De Gramont, A
Kruuk, M
Citation: L. Vedrine et al., Carcinomatous meningitis in gastric cancer, GASTRO CL B, 25(4), 2001, pp. 422-424
Authors:
Artru, P
Tournigand, C
Mabro, M
Lucchi, E
Louvet, C
De Gramont, A
Krulik, M
Citation: P. Artru et al., Primary hyperparathyroidism associated with colon cancer, GASTRO CL B, 25(2), 2001, pp. 208-209
Authors:
Andre, T
Colin, P
Louvet, C
Gamelin, E
Bouche, O
Achille, E
Colbert, N
Boaziz, C
Piedbois, P
Tubiana-Mathieu, N
Boutan-Laroze, A
Flesch, M
Billiau, V
Buyse, M
de Gramont, A
Citation: T. Andre et al., Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results, SEMIN ONCOL, 28(1), 2001, pp. 35-40
Authors:
Tournigand, C
Louvet, C
Molitor, JL
Dehni, N
Lejeune, V
Sezeur, A
Pigne, A
Marpeau, L
Cady, J
de Gramont, A
Citation: C. Tournigand et al., Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 198-204
Authors:
Louvet, C
de Gramont, A
Tournigand, C
Artru, P
Maindrault-Goebel, F
Krulik, M
Citation: C. Louvet et al., Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma, CANCER, 91(11), 2001, pp. 2033-2038
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
de Gramont, A
Citation: T. Andre et al., Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer, B CANCER, 88, 2001, pp. S20-S25
Authors:
Raymond, E
Faivre, S
Coudray, AM
Louvet, C
Gespach, C
Citation: E. Raymond et al., Preclinical studies of oxaliplatin in combination chemotherapy, B CANCER, 88, 2001, pp. S26-S34
Authors:
Louvet, C
Coudray, AM
Tournigand, C
Prevost, S
Raymond, E
de Gramont, A
Chazard, M
Gespach, C
Citation: C. Louvet et al., Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice, ANTI-CANC D, 11(7), 2000, pp. 579-582
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
de Gramont, A
Figer, A
Seymour, M
Homerin, M
Hmissi, A
Cassidy, J
Boni, C
Cortes-Funes, H
Cervantes, A
Freyer, G
Papamichael, D
Le Bail, N
Louvet, C
Hendler, D
de Braud, F
Wilson, C
Morvan, F
Bonetti, A
Citation: A. De Gramont et al., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J CL ONCOL, 18(16), 2000, pp. 2938-2947
Authors:
Bechade, D
Algayres, JP
Baranger, B
Arborio, M
Louvet, C
Krulik, M
Bili, H
Coutant, G
Daly, JP
Citation: D. Bechade et al., Malignant peritoneal mesothelioma revealed by small bowel obstruction, GASTRO CL B, 24(12), 2000, pp. 1237-1240
Authors:
Andre, T
Balosso, J
Louvet, C
Hannoun, L
Houry, S
Huguier, M
Colonna, M
Lotz, JP
De Gramont, A
Bellaiche, A
Parc, R
Touboul, E
Izrael, V
Citation: T. Andre et al., Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study, INT J RAD O, 46(4), 2000, pp. 903-911
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Brienza, S
Bensmaine, MA
Soulie, P
Louvet, C
Gamelin, E
Francois, E
Ducreux, M
Marty, M
Andre, T
de Braud, F
Bleiberg, H
Segal, V
Itzhaki, M
Cvitkovic, E
Citation: S. Brienza et al., Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program, ANN ONCOL, 10(11), 1999, pp. 1311-1316
Authors:
Andre, T
Bensmaine, MA
Louvet, C
Francois, E
Lucas, V
Desseigne, F
Beerblock, K
Bouche, O
Carola, E
Merrouche, Y
Morvan, F
Dupon-Andre, G
de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568
Authors:
Sezeur, A
De Gramont, A
Touboul, E
Beaugerie, L
Gallot, D
Cattan, S
Betton, PO
Carbonnel, F
Martel, P
Tarlat, E
Louvet, C
Cosnes, J
Housset, M
Malafosse, M
Citation: A. Sezeur et al., Contribution of the telemedicine applied to digestive cancerology., GASTRO CL B, 23(3), 1999, pp. 342-347
Authors:
Mabro, M
Gilles-Amar, V
Louvet, C
Carola, E
Maindrault-Goebel, F
de Gramont, A
Krulik, M
Citation: M. Mabro et al., Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients., REV MED IN, 20(10), 1999, pp. 863-868
Authors:
Andre, T
Louvet, C
Raymond, E
Tournigand, C
de Gramont, A
Citation: T. Andre et al., Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen, ANN ONCOL, 9(11), 1998, pp. 1251-1253
Authors:
Andre, T
Chastre, E
Kotelevets, L
Vaillant, JC
Louvet, C
Balosso, J
Le Gall, E
Prevot, S
Gespach, C
Citation: T. Andre et al., Tumoral angiogenesis: physiopathology, prognostic value and therapeutical prospects, REV MED IN, 19(12), 1998, pp. 904-913
Risultati:
1-23
|